448 related articles for article (PubMed ID: 12028458)
1. Outcome of relapse in lupus nephritis: roles of reversal of renal fibrosis and response of inflammation to therapy.
Hill GS; Delahousse M; Nochy D; Thervet E; Vrtovsnik F; Rémy P; Glotz D; Bariéty J
Kidney Int; 2002 Jun; 61(6):2176-86. PubMed ID: 12028458
[TBL] [Abstract][Full Text] [Related]
2. Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages.
Hill GS; Delahousse M; Nochy D; Rémy P; Mignon F; Méry JP; Bariéty J
Kidney Int; 2001 Jan; 59(1):304-16. PubMed ID: 11135084
[TBL] [Abstract][Full Text] [Related]
3. A new morphologic index for the evaluation of renal biopsies in lupus nephritis.
Hill GS; Delahousse M; Nochy D; Tomkiewicz E; Rémy P; Mignon F; Méry JP
Kidney Int; 2000 Sep; 58(3):1160-73. PubMed ID: 10972679
[TBL] [Abstract][Full Text] [Related]
4. Proteinuria and tubulointerstitial lesions in lupus nephritis.
Hill GS; Delahousse M; Nochy D; Mandet C; Bariéty J
Kidney Int; 2001 Nov; 60(5):1893-903. PubMed ID: 11703608
[TBL] [Abstract][Full Text] [Related]
5. Class IV-S versus class IV-G lupus nephritis: clinical and morphologic differences suggesting different pathogenesis.
Hill GS; Delahousse M; Nochy D; Bariéty J
Kidney Int; 2005 Nov; 68(5):2288-97. PubMed ID: 16221231
[TBL] [Abstract][Full Text] [Related]
6. Interstitial inflammation and long-term renal outcomes in lupus nephritis.
Alsuwaida AO
Lupus; 2013 Dec; 22(14):1446-54. PubMed ID: 24097970
[TBL] [Abstract][Full Text] [Related]
7. Collapsing glomerulopathy in 19 patients with systemic lupus erythematosus or lupus-like disease.
Salvatore SP; Barisoni LM; Herzenberg AM; Chander PN; Nickeleit V; Seshan SV
Clin J Am Soc Nephrol; 2012 Jun; 7(6):914-25. PubMed ID: 22461531
[TBL] [Abstract][Full Text] [Related]
8. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.
Conlon PJ; Fischer CA; Levesque MC; Smith SR; St Clair EW; Allen NB; Fleming JA; Howell DN
Clin Nephrol; 1996 Sep; 46(3):170-5. PubMed ID: 8879851
[TBL] [Abstract][Full Text] [Related]
9. Analysis of clinicopathologic correlations in Iranian patients with lupus nephritis.
Shariati-Sarabi Z; Ranjbar A; Monzavi SM; Esmaily H; Farzadnia M; Zeraati AA
Int J Rheum Dis; 2013 Dec; 16(6):731-8. PubMed ID: 24382282
[TBL] [Abstract][Full Text] [Related]
10. Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis.
Mok CC; Ying KY; Tang S; Leung CY; Lee KW; Ng WL; Wong RW; Lau CS
Arthritis Rheum; 2004 Aug; 50(8):2559-68. PubMed ID: 15334470
[TBL] [Abstract][Full Text] [Related]
11. An observational study of outcome in SLE patients with biopsy-verified glomerulonephritis between 1986 and 2004 in a defined area of southern Sweden: the clinical utility of the ACR renal response criteria and predictors for renal outcome.
Nived O; Hallengren CS; Alm P; Jönsen A; Sturfelt G; Bengtsson AA
Scand J Rheumatol; 2013; 42(5):383-9. PubMed ID: 23829689
[TBL] [Abstract][Full Text] [Related]
12. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
Shen K; Yu Y; Tang Z; Liu Z; Li L
Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
[TBL] [Abstract][Full Text] [Related]
13. [Clinical course and prognostic factors in lupus nephropathy].
Gamba G; Quintanilla L; del Bosque MD; Chew-Wong A; Correa-Rotter R
Rev Invest Clin; 2000; 52(4):397-405. PubMed ID: 11061101
[TBL] [Abstract][Full Text] [Related]
14. Interstitial inflammatory and chronic tubulointerstitial lesions in lupus nephritis: comparison with those in IgA nephropathy.
Yamamoto T; Nagase M; Hishida A; Honda N
Lupus; 1993 Aug; 2(4):261-8. PubMed ID: 8268975
[TBL] [Abstract][Full Text] [Related]
15. Remission of lupus nephritis: the trajectory of histological response in successfully treated patients.
Malvar A; Alberton V; Lococo B; Lourenco M; Martinez J; Burna L; Besso C; Navarro J; Nagaraja HN; Khatiwada A; Wolf B; Rovin B
Lupus Sci Med; 2023 May; 10(1):. PubMed ID: 37258036
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of repeat biopsy in lupus nephritis: Histopathologic worsening and a short time between biopsies is associated with significantly increased risk for end stage renal disease and death.
Arriens C; Chen S; Karp DR; Saxena R; Sambandam K; Chakravarty E; James JA; Merrill JT
Clin Immunol; 2017 Dec; 185():3-9. PubMed ID: 27923701
[TBL] [Abstract][Full Text] [Related]
17. Remission of proteinuria indicates good prognosis in patients with diffuse proliferative lupus nephritis.
Koo HS; Kim S; Chin HJ
Lupus; 2016 Jan; 25(1):3-11. PubMed ID: 26159540
[TBL] [Abstract][Full Text] [Related]
18. Long-term renal outcomes in multi-ethnic Southeast Asians with lupus nephritis: a retrospective cohort study.
Lim CC; Tan HZ; Hao Y; Chin YM; Woo KT; Chan CM; Choo JCJ
Intern Med J; 2018 Sep; 48(9):1117-1123. PubMed ID: 29740923
[TBL] [Abstract][Full Text] [Related]
19. Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 International Society of Nephrology and Renal Pathology Society system.
Yu F; Wu LH; Tan Y; Li LH; Wang CL; Wang WK; Qu Z; Chen MH; Gao JJ; Li ZY; Zheng X; Ao J; Zhu SN; Wang SX; Zhao MH; Zou WZ; Liu G
Kidney Int; 2010 May; 77(9):820-9. PubMed ID: 20182417
[TBL] [Abstract][Full Text] [Related]
20. Severity of systemic lupus erythematosus with diffuse proliferative glomerulonephritis and the ineffectiveness of standard pulse intravenous cyclophosphamide therapy in Jamaican patients.
Williams W; Bhagwandass A; Sargeant LA; Shah D
Lupus; 2003; 12(8):640-5. PubMed ID: 12945726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
